BioSpace News Archive

Teva Announces the Launch of a Generic Version of ALOXI® in the United States

Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the launch of a generic version of ALOXI®1 (palonosetron HCI) injection, 0.25 mg/5 mL, in the United States

March 23, 2018
·
8 min read
Business

Can-Fite Reports 2017 Financial Results & Provides Clinical Update

A multi-million dollar agreement has been signed with Gebro Holdings for the distribution of Piclidenoson in 3 European Countries

March 23, 2018
·
14 min read
Biotech Beach

Male Birth Control Pill Shows Promise

A breakthrough in oral male contraception, researchers show feasibility of “the pill” for men.

March 23, 2018
·
2 min read
Business

Nuvo Pharmaceuticals Announces 2017 Fourth Quarter and Year-End Results

Nuvo to Host Conference Call/Audio Webcast March 23 at 8:30 a.m. ET

March 23, 2018
·
22 min read
FDA

Auris Health Unveils the FDA-Cleared Monarch Platform, Ushering in a New Era of Medical Intervention

Company’s First Application of Its Innovative Flexible Robotics Platform Is Bronchoscopy

March 23, 2018
·
4 min read
Business

Aradigm Announces Fourth Quarter 2017 and Full Year Financial Results

Cash and cash equivalents of $7.1 million expected to be sufficient to fund operations for Q1 2018; temporary measures implemented to preserve cash resources.

March 23, 2018
·
9 min read
Policy

St. Baldrick’s Foundation Announces the Childhood Cancer STAR Act Approved by Senate, Moves to House of Representatives

The St. Baldrick’s Foundation, the largest private funder of childhood cancer research grants, is pleased to announce that the Childhood Cancer Survivorship Treatment Access and Research (STAR) Act has been passed by the Senate, and is now being sent to the House of Representatives for consideration.

March 23, 2018
·
2 min read
Pharm Country

Data Shows That the Global Addiction Treatment Market is Set to Grow

Data provided by Transparency Market Research, indicates that global addiction treatment market was valued at approximately US$ 4.0 billion in 2016 and is anticipated to expand at a CAGR of over 6.0% from 2017 to 2025 or reaching value of approximately US$ 7.0 billion by 2025.

March 23, 2018
·
10 min read
BioMidwest

Stryker F1™ Small Bone Power System brings fresh innovation to the power tool market

Stryker’s Instruments division announced today the launch of the Stryker F1™ Small Bone Power System, providing surgeons with a cordless, balanced, lightweight solution for procedures of the extremities.

March 23, 2018
·
3 min read
Policy

National Kidney Foundation Applauds Bi-Partisan Funding for Kidney Health in Omnibus Spending Bill

Bi-partisan legislation will protect kidney patients and ensure funding for kidney disease programs

March 23, 2018
·
3 min read